There’s a little problem, though: most of the decline in the seven comes down to one company. Apple is down 14 per cent since ...

Analysis of Sasol’s trading update, the GLP-1 drug boom, and why Simon says: “don’t trust, verify” when it comes to big ...

Altimmune, Inc. (NASDAQ:ALT), a biopharmaceutical company with a market capitalization of $503.56 million focused on ...

About one in eight adults in the United States has tried or currently uses a GLP-1 medication, and a quarter of those users ...

Oprah Winfrey opens up on her podcast about her weight-loss journey with anti-obesity GLP-1 medications while chatting with doctors and guests. Plus, the media icon shares how her opinion of "thin ...

Everyone is talking about this as renowned media mogul Oprah Winfrey is facing significant backlash after her recent remarks about "thin people" during a podcast episode with Dr. A ...

With the recent surge in popularity of weight loss drugs like Ozempic, altogether called GLP-1s, there has been renewed scientific interest in understanding how our bodies regulate muscle growth.

Texas Instruments reported lower profit and revenue in the fourth quarter, while its first-quarter outlook missed expectations. The chipmaker reported a profit of $1.21 billion on revenue of $4.01 ...

Shantanu Gaur, the founder and chief executive of Allurion, said the goal of the study would be to prove that combining the Allurion Balloon and Allurion Virtual Care Suite with GLP-1 therapy would ...

GLP-1 agonist initiators had a significantly higher likelihood of undergoing thyroid ultrasonography at 6 and 12 months, ...

The media mogul is being criticized by some for statements she made about thin people on the latest episode of her podcast.

Allurion Technologies (ALUR) announced its intention to initiate a clinical study on the combination of the Allurion Program with GLP-1 ...